12:36 PM EST - Quest PharmaTech Inc. : a pharmaceutical company announced that its 12-patient, Phase I clinical study entitled ''ACP-SL017 Topical Gel: A Phase I Study for the Photodynamic Therapy of Actinic Keratosis'' has met both its primary and exploratory objectives. Quest PharmaTech Inc.
shares V.QPT are trading up 34.12 percent at $0.19.
